Lysine for Calcium Absorption

Calcium Absorption — scientific infographic poster

Lysine, an essential amino acid, has been studied for a possible effect on how the body absorbs and keeps calcium. The human evidence is small. The main study, by Roberto Civitelli, Louis Avioli, Carlo Gennari and colleagues (published in Nutrition in 1992), combined two short experiments: in 15 healthy and 15 osteoporotic women given a single 3 g oral calcium load, adding 400 mg of L-lysine blunted the rise in urinary calcium in the healthy women; and in 45 osteoporotic patients, short-term L-lysine (800 mg/day) raised intestinal calcium absorption measured with a 47-calcium tracer, while L-valine and L-tryptophan did not. The authors suggested a possible role for lysine in osteoporosis, but no trial has tested lysine against bone density or fracture outcomes, and a 2025 review lists lysine in osteoporosis therapy as a question still needing investigation (Holeček 2025).


Table of Contents

  1. Calcium Absorption Mechanisms (Active vs Passive)
  2. The Civitelli 1992 Calcium Studies
  3. Proposed Mechanisms: Chelation and Solubilization
  4. Urinary Calcium
  5. Lysine Alongside Calcium, Vitamin D and Vitamin K2
  6. Lysine and the Bone Collagen Matrix
  7. Osteoporosis Evidence and Its Limits
  8. Lysine in Cereal-Staple Diets
  9. Kidney Stones and Hypercalciuria
  10. Doses Used in Studies
  11. Cautions
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Calcium Absorption Mechanisms (Active vs Passive)

Intestinal calcium absorption is usually described as the sum of two pathways (Fleet and Schoch 2010). The saturable, transcellular pathway carries calcium through the intestinal cells; textbook descriptions give apical entry through TRPV6 channels, carriage across the cell bound to calbindin-D9k, and export by the PMCA1b calcium pump. Habitual low calcium intake up-regulates this pathway through increased production of 1,25-dihydroxyvitamin D (calcitriol), and low vitamin D status or defects in the vitamin D receptor limit it.

The non-saturable pathway depends mainly on how much calcium is in the gut lumen; calcium moves between cells through the tight junctions. There is some evidence that this pathway in the ileum is also influenced by vitamin D status, but the mechanism is unclear (Fleet and Schoch 2010).

Absorption efficiency varies widely between people. In a 17-year series of 526 absorption studies in 189 middle-aged women, the fraction absorbed fell as intake rose (from about 45% at intakes near 200 mg/day to about 15% above 2,000 mg/day), declined slowly with age, and dropped once more at menopause (Heaney 1989).

Which of these pathways lysine might act on has not been established. The Civitelli studies measured total absorption and urinary calcium, not individual transport steps.

Back to Table of Contents

The Civitelli 1992 Calcium Studies

The human paper is Civitelli R, Villareal DT, Agnusdei D, Nardi P, Avioli LV, Gennari C (1992). Dietary L-lysine and calcium metabolism in humans. Nutrition (Institute of Medical Pathology, University of Siena). The authors note that earlier animal studies had shown that some amino acids, particularly L-lysine, can increase calcium absorption. The work received the 1992 John M. Kinney International Award for Nutrition and Metabolism (Civitelli 1993). It contains two separate experiments:

The authors concluded that L-lysine can both enhance intestinal calcium absorption and improve renal conservation of absorbed calcium, and that the combined effects “may contribute” to a positive calcium balance, suggesting a potential use for lysine supplements in osteoporosis. The abstract does not report effect sizes as percentages, parathyroid hormone results, or nitrogen or amino acid balance.

Limits worth knowing: both experiments were short; the urinary effect was seen after a single large calcium load and only in the healthy women; and the absorption experiment measured tracer uptake, not bone density or fractures. A related laboratory study by the same group found that, in cultured human skin fibroblasts, removing lysine from the growth medium raised intracellular calcium and reduced calcium efflux, while removing arginine had no effect (Civitelli 1989) — a cell-culture finding, not a human result. No larger human study repeating the 1992 design was identified in PubMed.

Back to Table of Contents

Proposed Mechanisms: Chelation and Solubilization

How lysine might raise calcium absorption is not known. One proposed explanation is that lysine, or other amino acids, form soluble complexes with calcium in the gut and keep it from precipitating with phosphate or binding to oxalate and phytate. The early rat work on amino acids and the absorption of calcium-45 and strontium-89 (Wasserman, Comar and Nold 1956) is often cited in this context. No human study identified for this page tested the chelation explanation directly.

The effect of oxalate on calcium itself is well measured. In a randomized cross-over study in 13 healthy adults given test meals with 200 mg of labelled calcium, mean calcium absorption was 27.6% from milk and 5.1% from spinach, whose oxalate slightly exceeded its calcium (Heaney 1988). Whether lysine changes absorption from high-oxalate or high-phytate foods has not been studied.

Calcium salts such as citrate, malate and glycinate, and calcium-amino-acid complexes, are sold as supplements; no study was identified comparing free lysine taken with a meal against such a complex.

Back to Table of Contents

Urinary Calcium

The second finding in the Civitelli paper concerns the kidney. After a 3 g oral calcium load, urinary calcium rose in all groups except the healthy women who were also given 400 mg of lysine, whose calciuric response was blunted. Serum calcium rose in all groups. The osteoporotic women given lysine did not show the blunted response. The authors interpreted the finding as improved renal conservation of the absorbed calcium; the mechanism was not studied.

Urinary calcium is shaped by many dietary factors. In short-term trials in healthy adults with calcium intake held constant, raising dietary protein from 0.7 to 2.1 g/kg increased urinary calcium in 20 women, and also increased intestinal calcium absorption, from 18.4% to 26.3%; protein intakes at and below 0.8 g/kg were associated with a probable fall in calcium absorption (Kerstetter 2003). Lysine is one component of dietary protein, and the wider literature on protein, amino-acid-sensing receptors and calcium is reviewed by Conigrave, Brown and Rizzoli (2008) and Heaney (2007).

No trial of lysine in people with idiopathic hypercalciuria was identified in PubMed.

Back to Table of Contents

Lysine Alongside Calcium, Vitamin D and Vitamin K2

Lysine is often discussed together with the better-studied nutrients for bone:

No trial was identified that tested lysine combined with calcium, vitamin D and vitamin K against bone density or fractures, so the size of any combined effect is unknown.

Magnesium, boron and zinc are also discussed in relation to bone; the Morley Robbins series covers one practitioner's view of mineral balance.

Back to Table of Contents

Lysine and the Bone Collagen Matrix

Bone is a composite: hydroxyapatite mineral laid down on a type I collagen scaffold. The mineral gives stiffness and compressive strength; the collagen gives tensile strength and resistance to cracking. In osteogenesis imperfecta (“brittle bone disease”), mutations affecting type I collagen lead to repeated low-impact fractures.

Bone collagen goes through the same lysine chemistry as collagen elsewhere: lysyl hydroxylases (which need vitamin C) hydroxylate specific lysines, and the copper-dependent enzyme lysyl oxidase starts the cross-links, as described on the Collagen Synthesis page. Whether extra dietary lysine improves bone collagen in people who already eat enough protein has not been tested in published human trials.

Pyridinoline (PYD) and deoxypyridinoline (DPD) are lysine-derived collagen cross-links. They are released when bone is resorbed, so urinary PYD and DPD have been used as markers of bone resorption. Raised levels reflect increased bone breakdown, not a shortage or surplus of dietary lysine.

Back to Table of Contents

Osteoporosis Evidence and Its Limits

The evidence linking lysine to osteoporosis is limited to the following:

No randomized trial of lysine with bone mineral density or fracture outcomes was identified in PubMed, so lysine has not been shown to prevent or treat osteoporosis. Established osteoporosis treatments have been tested in large fracture-outcome trials; lysine has not. Decisions about supplements and bone treatment belong with a clinician.

Back to Table of Contents

Lysine in Cereal-Staple Diets

Lysine is the limiting amino acid in diets based on wheat as the staple (Smriga 2004). Protein quality is commonly scored by the protein digestibility-corrected amino acid score (PDCAAS), adopted by FAO/WHO, which compares a protein's first limiting essential amino acid with a reference pattern; by such evaluations milk proteins are superior to plant proteins in cereal-based diets (Schaafsma 2000). Cereal proteins are low in lysine and legume proteins are relatively rich in it, which is why cereal-and-legume combinations are described as complementary.

Lysine fortification has been tested in randomized trials in low-income communities, but none measured bone:

Whether long-term low lysine intake in cereal-staple populations affects peak bone mass or fracture risk has not been studied directly. Mixed diets that include legumes or animal protein generally supply ample lysine; intake is lowest in diets built mainly on cereals with little legume or animal protein.

Back to Table of Contents

Kidney Stones and Hypercalciuria

Calcium oxalate stones, the most common kidney stone type, form when urine is supersaturated with calcium and oxalate. The lysine evidence here is limited to laboratory and observational work:

No clinical trial of lysine for kidney-stone prevention was identified in PubMed, and no stone-prevention guideline identified for this page includes lysine.

Cystinuria is a different, inherited stone disease. It is caused by mutations in SLC3A1 and SLC7A9, which encode the two subunits (rBAT and b0,+AT) of a kidney transporter that reabsorbs cystine and the dibasic amino acids, lysine among them (Eggermann 2012). Because lysine uses the same transporter, the research raises a theoretical concern about lysine loading in people with cystinuria; this has not been tested in trials.

Back to Table of Contents

Doses Used in Studies

No dose of lysine has been established for calcium absorption or bone health, because no trial has measured bone outcomes. Doses used for other purposes, such as herpes, are covered on the Herpes Prevention page. Decisions about supplements belong with a clinician.

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Civitelli R, Villareal DT, Agnusdei D, Nardi P, Avioli LV, Gennari C (1992). Dietary L-lysine and calcium metabolism in humans. Nutrition 8(6):400-5. — PubMed PMID: 1486246
  2. Wasserman RH, Comar CL, Nold MM (1956). The influence of amino acids and other organic compounds on the gastrointestinal absorption of calcium 45 and strontium 89 in the rat. Journal of Nutrition 59(3):371-83. — PubMed PMID: 13357972
  3. Pellegrino ED, Biltz RM (1965). The composition of human bone in uremia. Observations on the reservoir functions of bone and demonstration of a labile fraction of bone carbonate. Medicine (Baltimore) 44(5):397-418. — PubMed PMID: 5318076
  4. Conigrave AD, Brown EM, Rizzoli R (2008). Dietary protein and bone health: roles of amino acid-sensing receptors in the control of calcium metabolism and bone homeostasis. Annual Review of Nutrition 28:131-55. — PubMed PMID: 18466091
  5. Heaney RP, Recker RR, Stegman MR, Moy AJ (1989). Calcium absorption in women: relationships to calcium intake, estrogen status, and age. Journal of Bone and Mineral Research 4(4):469-75. — PubMed PMID: 2816496
  6. Smriga M, Ghosh S, Mouneimne Y, Pellett PL, Scrimshaw NS (2004). Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria. Proceedings of the National Academy of Sciences 101(22):8285-8. — PubMed PMID: 15159538
  7. Ghosh S, Smriga M, Vuvor F, Suri D, Mohammed H, Armah SM, Scrimshaw NS (2010). Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana. American Journal of Clinical Nutrition 92(4):928-39. — PubMed PMID: 20720257
  8. Heaney RP (2007). Effects of protein on the calcium economy. International Congress Series 1297:191-7. — doi:10.1016/j.ics.2006.08.025
  9. Kerstetter JE, O'Brien KO, Insogna KL (2003). Dietary protein, calcium metabolism, and skeletal homeostasis revisited. American Journal of Clinical Nutrition 78(3 Suppl):584S-592S. — PubMed PMID: 12936953
  10. Rizzoli R, Stevenson JC, Bauer JM, et al. (2014). The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 79(1):122-32. — PubMed PMID: 25082206
  11. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014). Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. Journal of Clinical Endocrinology and Metabolism 99(10):3561-9. — PubMed PMID: 25162665
  12. Schaafsma G (2000). The protein digestibility-corrected amino acid score. Journal of Nutrition 130(7):1865S-7S. — PubMed PMID: 10867064
  13. Civitelli R (1993). The 1992 John M. Kinney International Award for Nutrition and Metabolism. Dietary L-lysine and calcium metabolism in humans: background. Nutrition 9(3):299-300. — PubMed PMID: 8353378
  14. Civitelli R, Fedde KN, Harter J, Halstead LR, Gennari C, Avioli LV (1989). Effect of L-lysine on cytosolic calcium homeostasis in cultured human normal fibroblasts. Calcified Tissue International 45(3):193-7. — PubMed PMID: 2505911
  15. Fleet JC, Schoch RD (2010). Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Critical Reviews in Clinical Laboratory Sciences 47(4):181-95. — PubMed PMID: 21182397
  16. Heaney RP, Weaver CM, Recker RR (1988). Calcium absorbability from spinach. American Journal of Clinical Nutrition 47(4):707-9. — PubMed PMID: 3354496
  17. Fini M, Giardino R, Mongiorgi R, et al. (1996). [Experimental osteoporosis caused by estrogen deficiency in rats. Role of a lactose, L-arginine and L-lysine combination in the prevention and therapy]. Minerva Medica 87(3):81-8 (in Italian). — PubMed PMID: 8668292
  18. Ghosh S, Pellett PL, Aw-Hassan A, Mouneime Y, Smriga M, Scrimshaw NS (2008). Impact of lysine-fortified wheat flour on morbidity and immunologic variables among members of rural families in northwest Syria. Food and Nutrition Bulletin 29(3):163-71. — PubMed PMID: 18947029
  19. Atanassova SS (2014). Influence of the lysine on the calcium oxalate renal calculi. International Urology and Nephrology 46(3):593-7. — PubMed PMID: 24057683
  20. Eggermann T, Venghaus A, Zerres K (2012). Cystinuria: an inborn cause of urolithiasis. Orphanet Journal of Rare Diseases 7:19. — PubMed PMID: 22480232
  21. Holeček M (2025). Lysine: sources, metabolism, physiological importance, and use as a supplement. International Journal of Molecular Sciences 26(18):8791. — PubMed PMID: 41009362

PubMed Topic Searches

  1. PubMed: Lysine calcium absorption intestinal
  2. PubMed: Lysine urinary calcium reduction
  3. PubMed: Lysine osteoporosis postmenopausal
  4. PubMed: Lysine fortification cereal growth
  5. PubMed: Lysine kidney stone hypercalciuria

Back to Table of Contents

Connections

Back to Table of Contents